Skip to main content

Headlines

Sensex, Nifty Slightly Higher Led By Pharma Stocks
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Ajanta Pharma (NSE:AJANTPHARM) Price Target Increased by 14.86% to 1,769.54
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Basilea Pharma Submits NDA For Antibiotic Ceftobiprole
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Hikma Pharma H1 Profit Down, Revenues Up; Lifts FY23 Forecast For Generics
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
US STOCKS-S&P 500, Nasdaq fall after mixed pharma earnings, economic data
posted:
by: Nasdaq MSFT MicroSoft
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #MSFT, #MicroSoft
US STOCKS-Futures slip ahead of economic data, Big Pharma results roll in
posted:
by: Nasdaq BABA Alibaba
#channels:: #All, #Business, #Technology, #Nasdaq, #Alibaba, #BABA, #Stocks
Goldman Sachs Maintains UroGen Pharma (URGN) Neutral Recommendation
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Citius Pharma: FDA Issues CRL For LYMPHIRTM BLA For Patients With Cutaneous T-cell Lymphoma
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Cantor Fitzgerald Reiterates Lumos Pharma (LUMO) Overweight Recommendation
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Morgan Stanley Reiterates Ascendis Pharma A (ASND) Equal-Weight Recommendation
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Pharma for Investors: Looking Beyond the Next Big Thing
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Piper Sandler Maintains Atyr Pharma (LIFE) Overweight Recommendation
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Pieris Pharma Cuts Around 70% Workforce; Plans Strategic Options
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
BridgeBio Pharma Reaches Analyst Target Price
posted:
by: Nasdaq ETFs
#channels:: #All, #Business, #Nasdaq, #NasdaqETFs, #ETFs, #Stocks
Acumen Pharma Reports Positive Trial Results Of ACU193 In Early Alzheimer's Disease
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks